Abstract:OBJECTIVE:To compare laboratory and clinical outcomes of in vitro fertilization-embryo transfer (IVF-ET) in patients with endometriosis using antagonist protocol, long agonist protocol or prolonged agonist protocol. METHODS:Totally 313 patients with endometriosis were recruited in Reproductive Centers of the Second Affiliated Hospital of Zhejiang University School of Medicine,Jiaxing Women and Children's Hospital,and Ningbo Women and Children's Hospital from April 2017 to October 2018, including 81 patients treated with antagonist protocol (antagonist group), 148 treated with long agonist protocol (long agonist group) and 84 treated with prolonged agonist protocol (prolonged agonist group). The clinical and laboratory data of the patients were retrospectively analyzed to investigate the effect of ovarian stimulation protocols on the IVF-ET outcomes of patients with endometriosis. RESULTS:The average age in the antagonist group patients was significantly higher than those in the other two groups (all P<0.05),and anti-mullerian hormone (AMH) level and antral follicle numbers were significantly lower than those in the other two groups (all P<0.01). The numbers of average retrieved oocyte, fertilized oocyte and available embryo in the antagonist group were significantly lower than those in the long agonist group (all P<0.05), but were similar with those in the prolonged agonist group (all P>0.05). Fertilization rate and available embryo rate were comparable among the three groups (all P>0.05). Considering analysis per cycle with embryo transfer, the human chorionic gonadotrophin (HCG) positive rate, clinical pregnancy rate and total implantation rate showed no significant difference among the three groups (all P>0.05). The implantation rate after fresh embryo transfer in the antagonist group was lower than that in the long agonist group (P<0.05), but was similar with that in the prolonged agonist group (P>0.05). While the implantation rate of freeze-thaw embryo transfer showed a higher trend in the antagonist group, but there was no significant difference (P>0.05). The patients were further divided into diminished and normal ovarian reserve subgroups, the per cycle with embryo transfer, the HCG positive rate, clinical pregnancy rate and total implantation rate still showed no significant difference between two subgroups (all P>0.05), no matter in which ovarian stimulation protocol groups. Besides, in women with diminished ovarian reserve, the available embryo rate in antagonist group was significantly higher than that in the long agonist group (P<0.05). The amount and duration of Gn application in antagonist group were significantly lower than those in long and prolonged agonist groups (all P<0.05). CONCLUSIONS:Patients with endometriosis who used the antagonist protocol in IVF procedure could reduce the cost and time of Gn treatment, when combined with frozen-embryo transfer strategy the antagonist protocol has comparable clinical pregnancy outcome with long or prolonged agonist protocol, especially in those with diminished ovarian reserve, the higher available embryo rate can be achieved.

Comparison of GnRH-a Prolonged Protocol and Short GnRH-a Long Protocol in Patients with Thin Endometrium for Assisted Reproduction: A Retrospective Cohort Study

DDDT_A_270519 3673..3682

Effects of Different Exposure Days to Gonadotropin-Releasing Hormone Agonist (Gnrh-A) on Live Birth Rates in the Depot GnRH-a Protocol: A Retrospective Analysis of 7007 Cycles

[Gonadotropin-Releasing Hormone Antagonist Protocol in Patients with Risk of Poor Response to Ovarian Stimulation in IVF-ET].

Controlled Ovarian Stimulation Protocols in Endometriosis Patients: with Antagonist or Agonist?

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium

Comparing the Long-Acting and Short-Acting Forms of Gonadotropin-Releasing Hormone Agonists in the Long Protocol of IVF/ICSI Cycles: A Retrospective Study.

[Comparison of Gonadotropin Releasing Hormone Agonist Long Protocol and Gonadotropin Releasing Hormone Antagonist Protocol in Infertile Women].

Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol

Comparison of two gonadotropin-releasing hormone agonist suppression protocols for in vitro fertilization in young patients with low body mass index

Comparison of GnRH Antagonist Fixed Protocol and GnRH Agonists Long Protocol in Infertile Patients with Normal Ovarian Reserve Function in Their First in Vitro Fertilization-Embryo Transfer Cycle

Comparison of GnRH-agonist long protocol with GnRH-antagonist protocol in women with advanced reproductive-age undergoing IVF-ET

Mini-dose GnRH-a Long Versus Short Protocol in Patients ≥ 35 Years Old Undergoing in Vitro Fertilization.

GnRH Antagonist Protocol Versus GnRH Agonist Long Protocol: A Retrospective Cohort Study on Clinical Outcomes and Maternal-Neonatal Safety

The Application of Long-Acting and Short-Acting Forms of Gonadotrophin-Releasing Hormone Agonists in Long Protocol of IVF/ICSI Cycles

Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study

Comparison of the Outcome of Different GnRH Agonist Down-regulation Regimens during In Vitro Fertilization-Embryo Transfer on Endometriosis

Comparison of Short 7-Day and Long Gonadotropin -Releasing Hormone Agonist Protocols in the Controlled Ovarian Stimulation for in Vitro Fertilization

Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?

Short Versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols In Ivf/Icsi Cycles In Patients Of Various Age Ranges

Effect of delayed initiation of gonadotropin in luteal long protocol on in vitro fertilization.